Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Immunotherapy|March 31, 2017
Chimeric antigen receptor engineered stem cells: a novel HIV therapyAnjie Zhen, Mayra A Carrillo, Scott G KitchenFrontiers in Immunology|May 15, 2018
The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and CancerMayra A Carrillo, Anjie Zhen, Scott G KitchenTranslational Research : the Journal of Laboratory and Clinical Medicine|July 31, 2017
New approaches for the enhancement of chimeric antigen receptors for the treatment of HIVMayra A Carrillo, Anjie Zhen, Jerome A Zack, et al.Frontiers in Cellular and Infection Microbiology|September 9, 2020
Engineering CAR T Cells to Target the HIV ReservoirWenli Mu, Mayra A Carrillo, Scott G KitchenMolecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2024
Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cellsMayra A Carrillo, Anjie Zhen, Wenli Mu, et al.Molecular Therapy. Methods & Clinical Development|August 14, 2023
Efficient manufacturing and engraftment of <i>CCR5</i> gene-edited HSPCs following busulfan conditioning in nonhuman primatesJason Murray, Teresa Einhaus, Rasika Venkataraman, et al.Trends in Biotechnology|January 6, 2026
CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogrammingMargaret R Wang, Wenli Mu, Anjie Zhen, et al.Plos Pathogens|August 30, 2021
Correction: Robust CAR-T memory formation and function via hematopoietic stem cell deliveryAnjie Zhen, Mayra A Carrillo, Wenli Mu, et al.Plos Pathogens|April 1, 2021
Robust CAR-T memory formation and function via hematopoietic stem cell deliveryAnjie Zhen, Mayra A Carrillo, Wenli Mu, et al.JCI Insight|December 12, 2022
Autophagy inducer rapamycin treatment reduces IFN-I-mediated Inflammation and improves anti-HIV-1 T cell response in vivoWenli Mu, Valerie Rezek, Heather Martin, et al.Pageof 8